Verseau bags $50M for cancer R&D, names Golumbeski as chairman by Nick Paul Taylor Monday, October 21, 2019 Verseau will use the money to start testing its macrophage checkpoint modulators in humans.
Refuge Biotech scores $25M from Chinese backers for CAR-T by Amirah Al Idrus Wednesday, May 2, 2018 Refuge's platform generates cells "that are programmed to make cancer-fighting decisions inside the patient's body."
